These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17009783)

  • 21. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.
    Palacios AR; Rossi MA; Mahler GS; Vila AJ
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32503337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico Design and Enantioselective Synthesis of Functionalized Monocyclic 3-Amino-1-carboxymethyl-β-lactams as Inhibitors of Penicillin-Binding Proteins of Resistant Bacteria.
    Decuyper L; Deketelaere S; Vanparys L; Jukič M; Sosič I; Sauvage E; Amoroso AM; Verlaine O; Joris B; Gobec S; D'hooghe M
    Chemistry; 2018 Oct; 24(57):15254-15266. PubMed ID: 29882610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.
    Fisher JF; Meroueh SO; Mobashery S
    Chem Rev; 2005 Feb; 105(2):395-424. PubMed ID: 15700950
    [No Abstract]   [Full Text] [Related]  

  • 25. Using steric hindrance to design new inhibitors of class C beta-lactamases.
    Trehan I; Morandi F; Blaszczak LC; Shoichet BK
    Chem Biol; 2002 Sep; 9(9):971-80. PubMed ID: 12323371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Lactamases: Why and How.
    Pratt RF
    J Med Chem; 2016 Sep; 59(18):8207-20. PubMed ID: 27232275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures of
    Lu Z; Wang H; Zhang A; Liu X; Zhou W; Yang C; Guddat L; Yang H; Schofield CJ; Rao Z
    Mol Pharmacol; 2020 Apr; 97(4):287-294. PubMed ID: 32086254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and studies of new forms of N-sulfonyloxy β-lactams as potential antibacterial agents and β-lactamase inhibitors.
    Carosso S; Miller MJ
    Bioorg Med Chem; 2015 Sep; 23(18):6138-47. PubMed ID: 26321604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
    Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
    Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclobutanone Analogues of β-Lactam Antibiotics: β-Lactamase Inhibitors with Untapped Potential?
    Devi P; Rutledge PJ
    Chembiochem; 2017 Feb; 18(4):338-351. PubMed ID: 27992105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meeting the challenges of beta-lactamases.
    Moellering RC
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():1-8. PubMed ID: 8449834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
    Caselli E; Powers RA; Blasczcak LC; Wu CY; Prati F; Shoichet BK
    Chem Biol; 2001 Jan; 8(1):17-31. PubMed ID: 11182316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.
    Ogawara H
    Microbiol Rev; 1981 Dec; 45(4):591-619. PubMed ID: 7035856
    [No Abstract]   [Full Text] [Related]  

  • 34. Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.
    Barry AL; Jones RN; Wilson HW; Badal RE; Thornsberry C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():97-112. PubMed ID: 6977536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Penicillin--binding protein: the target for beta-lactam antibiotics, beta-lactamases and their inhibitors].
    Lessel J
    Pharm Unserer Zeit; 1996 Jan; 25(1):17-27. PubMed ID: 8882750
    [No Abstract]   [Full Text] [Related]  

  • 36. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 37. Potent β-Lactam Enhancer Activity of Zidebactam and WCK 5153 against Acinetobacter baumannii, Including Carbapenemase-Producing Clinical Isolates.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclobutanone analogues of beta-lactams revisited: insights into conformational requirements for inhibition of serine- and metallo-beta-lactamases.
    Johnson JW; Gretes M; Goodfellow VJ; Marrone L; Heynen ML; Strynadka NC; Dmitrienko GI
    J Am Chem Soc; 2010 Mar; 132(8):2558-60. PubMed ID: 20141132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penicillin binding proteins, beta-lactams, and lactamases: offensives, attacks, and defensive countermeasures.
    Koch AL
    Crit Rev Microbiol; 2000; 26(4):205-20. PubMed ID: 11192022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.
    Moya B; Barcelo IM; Bhagwat S; Patel M; Bou G; Papp-Wallace KM; Bonomo RA; Oliver A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.